Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis (MS) or spinal cord injury.

In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line.

The HULC system was announced publicly at the AUSA Winter Symposium on February 26, 2009, when an exclusive licensing agreement was reached with Lockheed Martin.

[12] In 2016, Ekso Bionics appointed Thomas Looby interim chief executive officer, continues commercialization drive.

It can also decrease injury and increase production.In 2010 Berkeley Bionics unveiled eLEGS, which stands for "Exoskeleton Lower Extremity Gait System".

eLEGS is another pneumatically powered exoskeleton system, and allows paraplegics to stand and walk with crutches or a walker.

Ekso weighs 45 pounds (20 kg), has a maximum speed of 2 mph (3.2 km/h) and a battery life of 2-4 hours.

The suit's patented technology provides the ability to mobilize patients earlier, more frequently and with a greater number of high intensity steps.

It also added the ability to walk outside of the Ekso step trajectory, allowing for quick assessment of patient carryover while still in the device.

In June 2021, Ekso Bionics received FDA approval to use EksoNR with patients diagnosed with multiple sclerosis (MS), the first and only exoskeleton with this indication for use.

In October 2012, Parker Hannifin signed an exclusive licensing agreement with Vanderbilt University for the right to develop and manufacture a commercial version of the exoskeleton, which it planned to release under the name Indego.

Initially it included a software suite called Motion+, intended to assist those who are unable to ambulate to walk.

At the time of launch, the product was sold as a 3-piece kit, providing small, medium, and large sizes of each of the 5 pieces that make up the Indego (hip, 2x upper leg, 2x lower leg) Patients who utilize the Indego need to be less than 250lbs (113.4 kg) and have a seated hip width of 16.5” (42.2 cm) or less.

In 2016, the Indego was FDA approved for individuals with spinal cord injury at levels T4 to L5 to perform ambulatory functions in rehabilitation institutions.

The modular design is consistent with the therapy device, however, the Indego personal hip and upper legs are not adjustable.

In April 2024, PDAC determined a final payment level for Medicare reimbursement of the Ekso Indego Personal.

[33] Developed with Johns Hopkins University, EksoUE is a spin off from the EksoVest to be used in the healthcare setting under qualified therapists.

It is a passive, non-robotic system that provides spring powered assistance at the shoulders to amplify the users movements.

It has tool-less adjustability and is non-tethered, allowing users to walk around to different environments with it donned, separating it from its larger and static competitors like the Tyromotion Diego.

This was an industrial upper-body exoskeleton developed to support a worker’s arms and shoulders to assist with overhead work.

EksoVest provided support for tasks at chest height or overhead and was spring-powered, without the need for batteries or charging.

[37] Using feedback from the EksoVest, the Ekso Evo was modified to be more comfortable, lower in price, and retain less heat.

A new stacked link, sleek design minimizes body contact while still performing to the highest level to reduce fatigue and user injury in the workplace.